Skip to main content

JNJ

Stock

JNJ

Stock
Health Care
Drug Manufacturers - General

Performance overview

JNJ Price
Price Chart

Forward-looking statistics

Beta
0.37
Risk
19.71%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods.

Company info

SectorHealth Care
IndustryDrug Manufacturers - General
Employees144K
Market cap$354.0B

Fundamentals

Enterprise value$381.0B
Revenue$89.3B
Revenue per employee
Profit margin24.42%
Debt to equity66.90

Security info

ExchangeNyse American
Type of shareCommon Stock
Earnings per share (EPS)$8.99
Dividend per share$4.96
Revenue per share$37.11
Avg trading volume (30 day)$1B
Avg trading volume (10 day)$1B
Put-call ratio

Macro factor sensitivity

Growth+0.5
Credit+1.2
Liquidity-0.5
Inflation-1.1
Commodities+0.2
Interest Rates-0.4

Valuation

Dividend yield3.18%
PEG Ratio14.72
Price to sales4.20
P/E Ratio14.72
Enterprise Value to Revenue4.26
Price to book4.80

Upcoming events

Next earnings dayJuly 16, 2025
Next dividend day
Ex. dividend dayMay 27, 2025

News

Pre-Markets Red on Trump's Tariff Threats to Canada

Pre-Markets Red on Trump's Tariff Threats to Canada.

Zacks Investment Research (July 11, 2025)
Unveiling Johnson & Johnson (JNJ) Q2 Outlook: Wall Street Estimates for Key Metrics

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Johnson & Johnson (JNJ), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.

Zacks Investment Research (July 11, 2025)
3 AI-Driven Medical Device Stocks to Watch in 2025

BSX, JNJ and GEHC are leveraging AI to boost device performance, diagnostics and surgical precision in 2025.

Zacks Investment Research (July 11, 2025)
Johnson & Johnson Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Johnson & Johnson JNJ will release earnings results for the second quarter, before the opening bell on Wednesday, July 16.

Benzinga (July 11, 2025)
Pharma Companies Remain Calm Amid Fresh Tariff Threat by Trump

Trump revives tariff threats on pharma imports, but industry giants like LLY and JNJ stay unfazed with major U.S. investments underway.

Zacks Investment Research (July 10, 2025)
Trump threatens impose up to 200% tariff on pharmaceuticals 'very soon'

President Donald Trump threatened to impose up to 200% tariffs on pharmaceuticals imported into the U.S. "very soon."  But he suggested that those levies would not go into effect immediately, saying he will "give people about a year, year and a half.

CNBC (July 8, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free